bioRxivBiophysics
Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza
A. Ohno, N. Maita, T. Tabata, H. Nagano, K. Arita, M. Ariyoshi, T. Uchida, R. Nakao, A. Ulla, K. Sugiura, K. Kishimoto, S. Teshima-Kondo, Y. Okumura, T. Nikawa
Abstract
Infection of certain influenza viruses is triggered when its hemagglutinin (HA) is cleaved by host cell proteases such as proprotein convertases and type II transmembrane serine proteases (TTSP). HA with a monobasic motif is cleaved by trypsin-like proteases, including TMPRSS2 and HAT, while the multibasic motif found in high pathogenicity avian influenza HA is cleaved by furin, PC5/6, or MSPL. MSPL belongs to the TMPRSS family and preferentially cleaves [R/K]-K-K-R{downarrow} sequences. Here, we solved the crystal structure of the extracellular region of human MSPL in complex with an irreversible substrate-analog inhibitor. The structure revealed three domains clustered around the C-terminal -helix of the SPD. The inhibitor structure and its putative model show that the P1-Arg inserts into the S1 pocket, whereas the P2-Lys and P4-Arg interacts with the Asp/Glu-rich 99-loop that is unique to MSPL. Based on the structure of MSPL, we also constructed a homology model of TMPRSS2, which is essential for the activation of the SARS-CoV-2 spike protein and infection. The model may provide the structural insight for the drug development for COVID-19.
- organism: human
- assay: protein structure
- research focus: protein structure prediction
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hepatocyte growth factor activator inhibitor-2 rapidly inactivates airway-expressed human Type II Transmembrane Serine Proteases
Bryan J. Fraser, Ryan P. Wilson, … C.H. Arrowsmith·Journal of Biological ChemistryPeer-reviewed·Aug 12, 2026
- Analysis of the molecular determinants for furin cleavage of the spike protein S1/S2 site in defined strains of the prototype coronavirus murine hepatitis virus (MHV)
A. Choi, E. Kots, … G. Whittaker·bioRxiv·Jan 11, 2023
- SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses
M. Straus, J. T. Kinder, … G. R. Whittaker·VirologyPeer-reviewed·Apr 1, 2020
- Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design
W. Rut, Z. Lv, … S. K. Olsen·bioRxiv·Apr 29, 2020
- Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
J. Osipiuk, Saara‐Anne Azizi, … A. Joachimiak·Nature CommunicationsPeer-reviewed·Feb 2, 2021
- Structural basis of main proteases of coronavirus bound to drug candidate PF-07321332